Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Vigabatrin × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 1 Neoplasms 1 Epilepsy 1

Interventions

pembrolizumab 521 Specimen Handling 429 Carboplatin 393 Magnetic Resonance Spectroscopy 386 Cisplatin 367 Cyclophosphamide 350 Radiotherapy 325 Gemcitabine 276 Bevacizumab 269 Paclitaxel 259 Biopsy 252 Drug Therapy 245 Blood Specimen Collection 221 venetoclax 207 Nivolumab 204 fludarabine 202 Capecitabine 201 Oxaliplatin 195 Docetaxel 187 Injections 181 Fluorouracil 173 Radiosurgery 163 Dexamethasone 162 Rituximab 144 Pemetrexed 142 Standard of Care 137 Surgical Procedures, Operative 136 durvalumab 129 atezolizumab 127 tislelizumab 123

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04987463 2024-02-08

ViRap

Children's Memorial Health Institute, Poland

Phase 2/3 Recruiting

Epilepsy, Neoplasms, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡